Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
30.78
+0.16 (0.52%)
Jul 31, 2026, 4:08 PM HKT

Giant Biogene Holding Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,9152,0621,4521,002828.13
Depreciation & Amortization
81.9248.9833.6927.2423.94
Other Amortization
0.38-0.340.480.390.27
Loss (Gain) From Sale of Assets
-1.17-0.562.882.910.18
Loss (Gain) From Sale of Investments
-49.93-43.27-29.338.28-14.47
Loss (Gain) on Equity Investments
-9.53.6---
Stock-Based Compensation
45.2489.7220.5217.6616.49
Provision & Write-off of Bad Debts
-0.640.94-0.03-0.150.05
Other Operating Activities
-162.3-93.9839.654.94-104.34
Change in Accounts Receivable
-59.94-40.2-32.58-3.64-11.16
Change in Inventory
-82.48-113.51-17.77-94.36-24.61
Change in Accounts Payable
-88.14153.678.4631.04-8.33
Change in Unearned Revenue
-1.91-19.2224.7-3.2313.54
Change in Other Net Operating Assets
194.25-6.9275.01-61.49-27.28
Operating Cash Flow
1,7812,0411,647931.64692.4
Operating Cash Flow Growth
-12.77%23.90%76.83%34.55%-16.99%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-428.1-246.77-226.3-152.66-75
Sale of Property, Plant & Equipment
7.2----
Cash Acquisitions
-2.16----
Divestitures
--3.6933.13--
Sale (Purchase) of Intangibles
-0.72-0.01-2.13-0.59-0.13
Sale (Purchase) of Real Estate
-----19.53
Investment in Securities
-62.63-967-379.47-718.651,447
Other Investing Activities
167.68111.3547.4913.16210.72
Investing Cash Flow
-318.74-1,106-527.28-858.741,563

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-7.25-4.18-1.05-0.19-
Net Debt Issued (Repaid)
-7.25-4.18-1.05-0.19-
Issuance of Common Stock
2,3821,50456.4583.510.06
Repurchase of Common Stock
-166.15---6,236-
Common Dividends Paid
-644.79-908.44---
Dividends Paid
-644.79-908.44--367.46-2,550
Other Financing Activities
-11.29-7.97-3.54-11.67-68.62
Financing Cash Flow
917.99582.9551.81-5,7904,476

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-103.938.181.09-55.183.98
Net Cash Flow
2,2761,5261,173-5,7726,735

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,3531,7941,421778.97617.4
Free Cash Flow Growth
-24.63%26.27%82.44%26.17%-18.62%
Free Cash Flow Margin
24.51%32.40%40.33%32.95%39.77%
Free Cash Flow Per Share
1.281.791.450.760.62
Levered Free Cash Flow
819.891,4411,057-6,1045,352
Unlevered Free Cash Flow
820.081,4411,057-6,1045,352

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
447.58385205.76172.7218.26
Change in Working Capital
-38.22-26.24127.81-131.67-57.85